Angiogenesis and Lymphangiogenesis in Colon Cancer Metastasis

作者: Delphine Garnier , Janusz Rak

DOI: 10.1007/978-90-481-8833-8_9

关键词: ImmunologyCancer researchColorectal cancerBevacizumabMetastasisLymphangiogenesisCancerAngiogenesisGrowth factorMedicineMicrovesicles

摘要: The vascular system markedly contributes to the pathogenesis of colorectal cancer (CRC). Indeed, agents targeting angiogenesis (bevacizumab) exhibit considerable efficacy in treatment metastatic CRC, but less so other (adjuvant) settings. These unexpected outcomes indicate that, make further progress, a more complete understanding is required relationship between tumour cell compartment and various facets vasculature. Here, we review general mechanisms involved lymphangiogenesis during formation, growth dissemination CRC. We discuss several levels at which blood vessel regulated, namely through local factor networks, circulating effectors, coagulation system, microvesicles bone marrow-derived cells, latter acting systemic level. survey triggering proangiogenic state cancer, including microenvironment oncogenic pathways, developments anti-angiogenic therapy.

参考文章(298)
Daniel J. Dumont, Janet Rossant, Ron A Conlon, Terry P. Yamaguchi, Martin L. Breitman, tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors Oncogene. ,vol. 7, pp. 1471- 1480 ,(1992)
Annalisa Pacilli, Gianandrea Pasquinelli, Vascular wall resident progenitor cells: A review Experimental Cell Research. ,vol. 315, pp. 901- 914 ,(2009) , 10.1016/J.YEXCR.2008.12.018
Sandor Paku, N. Paweletz, First steps of tumor-related angiogenesis. Laboratory Investigation. ,vol. 65, pp. 334- 346 ,(1991)
Role of thrombin in angiogenesis and tumor progression. Seminars in Thrombosis and Hemostasis. ,vol. 30, pp. 63- 69 ,(2004) , 10.1055/S-2004-822971
Hideki Nishibori, Masaki Kitajima, Takeyoshi Yamauchi, Tetsuro Kubota, Yoshiyuki Ishii, Masahiko Watanabe, Kentaro Yamamoto, Hideki Tatematsu, Hirotoshi Hasegawa, The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer. Anticancer Research. ,vol. 23, pp. 245- 249 ,(2003)
Robert S. Kerbel, Joanne Yu, Jennifer Tran, Shan Man, Alicia Viloria-Petit, Giannoula Klement, Brenda L. Coomber, Janusz Rak, Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approaches. Cancer and Metastasis Reviews. ,vol. 20, pp. 79- 86 ,(2001) , 10.1023/A:1013172910858
Amato J. Giaccia, Genetic Basis of Altered Responsiveness of Cancer Cells to Their Microenvironment Rak, Janusz , Reprint Author Oncogene-directed therapies. pp. 113- 129 ,(2003) , 10.1007/978-1-59259-313-2_7
Janusz W Rak, Giannoula Klement, Robert S Kerbel, Joanne L Yu, Vascular endothelial growth factor isoform expression as a determinant of blood vessel patterning in human melanoma xenografts. Cancer Research. ,vol. 62, pp. 1838- 1846 ,(2002)